Board advances revised compounding rules to 15‑day public comment after hours of debate

The board (full name not specified in the transcript) voted on Jan. 8 to release revised regulations governing compounding of sterile and nonsterile drug preparations, hazardous drugs and radiopharmaceuticals for a 15‑day public comment period and to delegate follow‑up review authority to committee members.

Board president Sang Oh said the board is “a consumer protection agency charged with administering and enforcing pharmacy law,” and emphasized the board’s public‑protection mandate as members discussed changes intended to align state rules with national standards while clarifying California‑specific requirements.

Why it matters: The proposal responds to updates in United States Pharmacopeia (USP) compounding chapters and aims to reduce confusion among licensees about how federal USP standards and California regulations interact. The changes affect pharmacies, hospital compounding units, and other facilities that prepare compounded medications, with downstream effects for patients who rely on compounded sterile products and specialized formulations such as flavored pediatric suspensions and certain patient‑administered preparations.

Most important actions and outcomes

- At the meeting’s close, a motion by board member Maria (mover) and seconded by board member KK passed unanimously to: (1) accept staff responses to comments received during the 30‑day comment period consistent with the board’s discussion; (2) approve the recommended modified regulatory text for a 15‑day public comment period; and (3) delegate authority to members of the Enforcement and Compounding Committee (members Serpa and Barker, and the committee chair working with staff) to review additional comments received during that 15‑day period and advise the full board on final language. The motion passed on a recorded voice vote with all present members voting yes.

Scope of the revisions

Staff and board members reviewed multiple areas of the proposed text. Key proposals and clarifications discussed at the meeting include:

- Nonsterile compounding and flavoring: The package creates a…